Primary Job Title Director Primary Organization 
Phoenix
Gender Male
LinkedIn View on LinkedIn
Bernard Munos Bernard H. Munos is the founder of the InnoThink Center for Research in Biomedical Innovation, a consultancy that focuses on pharmaceutical innovation — specifically, where it comes from and how to get more of it. He previously served as an advisor for corporate strategy at Eli Lilly and Company, where he focused on disruptive
innovation and the radical redesign of research and development.
His work has been published in Nature and Science, and was recently profiled by Forbes magazine. This year, the popular industry publication FiercePharma named him one of the 25 most influential people in biopharmaceuticals today. Munos received his MBA from Stanford University and holds graduate degrees in agricultural economics and animal science from the University of California, Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences.
He is a Director of Phoenix Nest, a foundation dedicated to finding treatments for Sanfilippo syndrome, and serves on the Advisory Council and the Cures Acceleration Network Review Board of NIH's National Center for Advancing Translational Sciences (NCATS). He is also a non-executive Director for Glenmark Pharmaceuticals, and advises companies, government-funded research organizations, and disease foundations on how to become better innovators.
